Description

Chemical Properties

See individual entries for Cagrilintide and Semaglutide chemical properties.

Description

The CagriSema blend combines Cagrilintide, a long-acting amylin analog, with Semaglutide, a GLP-1 receptor agonist, to create a dual-pathway research model targeting complementary metabolic mechanisms. Cagrilintide modulates satiety signaling through amylin receptors while Semaglutide enhances insulin secretion and energy balance via GLP-1 pathways. Together, this combination is studied for its potential to produce enhanced effects on appetite regulation, glucose control, and weight management compared to either compound alone.